Genome-wide association study of BNT162b2 vaccine-related myocarditis identifies potential predisposing functional areas in Hong Kong adolescents
- PMID: 38844841
- PMCID: PMC11155081
- DOI: 10.1186/s12863-024-01238-6
Genome-wide association study of BNT162b2 vaccine-related myocarditis identifies potential predisposing functional areas in Hong Kong adolescents
Abstract
Vaccine-related myocarditis associated with the BNT162b2 vaccine is a rare complication, with a higher risk observed in male adolescents. However, the contribution of genetic factors to this condition remains uncertain. In this study, we conducted a comprehensive genetic association analysis in a cohort of 43 Hong Kong Chinese adolescents who were diagnosed with myocarditis shortly after receiving the BNT162b2 mRNA COVID-19 vaccine. A comparison of whole-genome sequencing data was performed between the confirmed myocarditis cases and a control group of 481 healthy individuals. To narrow down potential genomic regions of interest, we employed a novel clustering approach called ClusterAnalyzer, which prioritised 2,182 genomic regions overlapping with 1,499 genes for further investigation. Our pathway analysis revealed significant enrichment of these genes in functions related to cardiac conduction, ion channel activity, plasma membrane adhesion, and axonogenesis. These findings suggest a potential genetic predisposition in these specific functional areas that may contribute to the observed side effect of the vaccine. Nevertheless, further validation through larger-scale studies is imperative to confirm these findings. Given the increasing prominence of mRNA vaccines as a promising strategy for disease prevention and treatment, understanding the genetic factors associated with vaccine-related myocarditis assumes paramount importance. Our study provides valuable insights that significantly advance our understanding in this regard and serve as a valuable foundation for future research endeavours in this field.
Keywords: BNT162b2 vaccine; Clustering; Genetic risk predisposition; Vaccine side effect; Vaccine-induced myocarditis.
© 2024. The Author(s).
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures




Similar articles
-
Association of Myocarditis With BNT162b2 Messenger RNA COVID-19 Vaccine in a Case Series of Children.JAMA Cardiol. 2021 Dec 1;6(12):1446-1450. doi: 10.1001/jamacardio.2021.3471. JAMA Cardiol. 2021. PMID: 34374740 Free PMC article.
-
Postmarketing active surveillance of myocarditis and pericarditis following vaccination with COVID-19 mRNA vaccines in persons aged 12 to 39 years in Italy: A multi-database, self-controlled case series study.PLoS Med. 2022 Jul 28;19(7):e1004056. doi: 10.1371/journal.pmed.1004056. eCollection 2022 Jul. PLoS Med. 2022. PMID: 35900992 Free PMC article.
-
Myocarditis Following COVID-19 BNT162b2 Vaccination Among Adolescents in Hong Kong.JAMA Pediatr. 2022 Jun 1;176(6):612-614. doi: 10.1001/jamapediatrics.2022.0101. JAMA Pediatr. 2022. PMID: 35212709 Free PMC article.
-
Incidence, risk factors, natural history, and hypothesised mechanisms of myocarditis and pericarditis following covid-19 vaccination: living evidence syntheses and review.BMJ. 2022 Jul 13;378:e069445. doi: 10.1136/bmj-2021-069445. BMJ. 2022. PMID: 35830976 Free PMC article. Review.
-
Clinical characteristics and prognostic factors of myocarditis associated with the mRNA COVID-19 vaccine.J Med Virol. 2022 Apr;94(4):1566-1580. doi: 10.1002/jmv.27501. Epub 2021 Dec 14. J Med Virol. 2022. PMID: 34862617 Free PMC article.
References
-
- Pfizer-BioNTech. COVID-19 Vaccines. [cited 2023 16 Feb]; https://www.fda.gov/emergency-preparedness-and-response/coronavirus-dise....
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources